Mark Alles begins his post-Celgene career on the board of a US-China biotech led by a former colleague

Amber Tong

Antengene had Celgene written all over its brand. Its founder and CEO, Jay Mei, was the big biotech’s executive director of clinical development in hematology …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Mark Alles begins his post-Celgene career on the board of a US-China biotech led by a former colleague

Amber Tong

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Major FDA staff cuts would slow drug reviews, experts say

Updated: Bay Area biotech VC to shut down 15 months after launch, sources say, after key investor pulls out

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims

Roche heads to FDA with Gazyva results in a form of lupus

Bristol Myers prunes pipeline amid new round of cost cuts

Mark Alles be­gins his post-Cel­gene ca­reer on the board of a US-Chi­na biotech led by a for­mer col­league

Sign up to read this article for free.

more like this

Bachem

Bubendorf, BL, Switzerland

Mark Alles begins his post-Celgene career on the board of a US-China biotech led by a former colleague